E.coli-derived human CTCF recombinant protein (Position: K521-R727). Human CTCF shares 94% and 93.1% amino acid (aa) sequence identity with mouse and rat CTCF, respectively.
Each vial contains 50% glycerol, 0.9% NaCl, 0.2% Na2HPO4.
Purity:
Immunogen affinity purified.
Form:
Liquid
Target:
Transcriptional repressor CTCF
Application Dilute:
Western blot, Optimal dilutions should be determined by end users. Immunohistochemistry (Paraffin-embedded Section), Optimal dilutions should be determined by end users. ELISA, Optimal dilutions should be determined by end users.
* VAT and and shipping costs not included. Errors and price changes excepted